Studies assessing apelin-36 and apelin-12 levels in patients with nonalcoholic fatty liver disease (NAFLD) indicated that the elevation of this peptide did not persist after adjustment for potential confounders and rather attributed apelin elevation in these cases to obesity and IR that are closely associated with NAFLD [27, 28]. Here, APLN is linked to obesity due to melanocortin 4 receptor deficiency.